HOME >> BIOLOGY >> NEWS
Molecular therapeutics advance fight against brain cancer

(Philadelphia, PA) -- An estimated 41,000 new cases of primary brain tumors are expected to be diagnosed in 2004, according to the American Brain Tumor Association. To further narrow the gap between diagnosis and effective therapy, physicians at the University of Pennsylvania Health System now offer several promising approaches to brain tumor treatment, including novel imaging for oncologic neurosurgery and refined genetic testing for tumors to better target treatment.

Through enhanced magnetic resonance imaging (MRI), newer and broader information is helping to better guide tumor removal. MRI is used to measure the anatomy and metabolism of tumors. This informs surgeons pre- and post-operatively with a three-dimensional map of tumor-associated blood flow to more precisely assess the full extent of tumor growth versus conventional imaging methods. "This novel approach helps guide surgery and assessment of treatment response," says Donald M. O'Rourke, M.D., Associate Professor of Neurosurgery. These novel imaging methods are leading to increased patient survival by allowing for greater tumor removal in a safe manner.

Neuroscientists are also ushering in a new era in which genetics will dictate treatment. In the 1990s researchers noted that a more favorable prognosis in patients with certain brain tumors, primarily oligodendrogliomas, was associated with a deletion of genes on chromosomes 1 and 19. This genetic loss translates into a significant life-expectancy gain for some patients and is therefore a robust predictor that post-surgery chemotherapy should be given to such patients.

Patients with the genetic deletion on chromosome 1 have a median survival in certain cases of about 10 years and respond particularly well to chemotherapy given immediately after surgery. Patients with the deletion have slower-growing tumors and show a better response to chemotherapy; whereas, those without the deletion have relatively faster-growing tumors and are
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
4-Aug-2004


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular motor shuttles key protein in response to light
7. Molecular traffic cop directs cellular signals
8. Molecular marker predicts success of breast cancer treatment
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... , ... March 05, 2020 ... ... the formation of its Scientific Advisory Board (SAB) comprised of the industry’s ... immune-oncology centers, cell therapy centers, and private industry. Cytonus is a leading ...
(Date:3/5/2020)... ... 2020 , ... Diagenode, a leading global provider of complete ... of global genomics leader BGI Group, today announced a co-marketing agreement for Diagenode’s ... Pacific. , Under the terms of the non-exclusive agreement, the two companies ...
(Date:3/4/2020)... ... March 04, 2020 , ... Vitamin Science, Inc, a manufacturer ... multi-dimensional nutraceutical formula for ocular blue light protection. , VisiVite Blue Light ... the retina’s healthy pigmentation and improve the eye’s management of high energy blue ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... (PRWEB) , ... March 10, 2020 , ... Ortho Clinical ... through innovative laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen ... transfusion, is cleared to run on ORTHO VISION® and ORTHO VISION® Max in the ...
(Date:3/3/2020)... ... March 03, 2020 , ... Frictionless Solutions, ... medical device industries, was recognized by INC. 5,000 on an annual list of ... note industry leaders greatly impacting their spheres of influence and experiencing considerable development. ...
(Date:2/21/2020)... ... February 20, 2020 , ... In a free session ... from Synteract including Lisa Dilworth, BS, MS, Vice President Rare, Orphan and ... with feasible strategies and solutions to support patients, sites and sponsors. , When planning ...
(Date:2/19/2020)... , ... February 18, 2020 , ... ... for characterizing microbiome populations down to the strain level, recently unveiled a novel ... designed for efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA ...
Breaking Biology Technology:
Cached News: